| An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors AC Latronico, EM Pinto, S Domenice, MCBV Fragoso, RM Martin, ... The Journal of Clinical Endocrinology & Metabolism 86 (10), 4970-4973, 2001 | 251 | 2001 |
| Genomic landscape of paediatric adrenocortical tumours EM Pinto, X Chen, J Easton, D Finkelstein, Z Liu, S Pounds, ... Nature communications 6 (1), 6302, 2015 | 184 | 2015 |
| Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors EM Pinto, AEC Billerbeck, MCBF Villares, S Domenice, BB Mendonça, ... Arquivos Brasileiros de Endocrinologia & Metabologia 48, 647-650, 2004 | 144 | 2004 |
| The International Pediatric Adrenocortical Tumor Registry initiative: contributions to clinical, biological, and treatment advances in pediatric adrenocortical tumors RC Ribeiro, EM Pinto, GP Zambetti, C Rodriguez-Galindo Molecular and Cellular Endocrinology 351 (1), 37-43, 2012 | 132 | 2012 |
| Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment APM Casarini, RS Jallad, EM Pinto, IC Soares, S Nonogaki, ... Pituitary 12, 297-303, 2009 | 90 | 2009 |
| Three novel mutations in CYP21 gene in Brazilian patients with the classical form of 21-hydroxylase deficiency due to a founder effect AEC Billerbeck, BB Mendonca, EM Pinto, G Madureira, IJP Arnhold, ... The Journal of Clinical Endocrinology & Metabolism 87 (9), 4314-4317, 2002 | 71 | 2002 |
| Evaluating the roles of follicle-stimulating hormone receptor polymorphisms in gonadal hyperstimulation associated with severe juvenile primary hypothyroidism GL Ryan, X Feng, CB d’Alva, M Zhang, BJ Van Voorhis, EM Pinto, ... The Journal of Clinical Endocrinology & Metabolism 92 (6), 2312-2317, 2007 | 67 | 2007 |
| An update on the central nervous system manifestations of Li–Fraumeni syndrome BA Orr, MR Clay, EM Pinto, C Kesserwan Acta neuropathologica 139 (4), 669-687, 2020 | 66 | 2020 |
| Classical osteoblastoma, atypical osteoblastoma, and osteosarcoma: a comparative study based on clinical, histological, and biological parameters CRGCM Oliveira, BB Mendonça, OP Camargo, EM Pinto, ... Clinics 62, 167-174, 2007 | 66 | 2007 |
| Treatment of pediatric adrenocortical carcinoma with surgery, retroperitoneal lymph node dissection, and chemotherapy: the Children's Oncology Group ARAR0332 protocol C Rodriguez-Galindo, MD Krailo, EM Pinto, F Pashankar, CB Weldon, ... Journal of Clinical Oncology 39 (22), 2463, 2021 | 65 | 2021 |
| Dissociation between tumor shrinkage and hormonal response during somatostatin analog treatment in an acromegalic patient: preferential expression of somatostatin receptor … APM Casarini, EM Pinto, RS Jallad, RR Giorgi, D Giannella-Neto, ... Journal of Endocrinological Investigation 29, 826-830, 2006 | 62 | 2006 |
| Deletion mapping of chromosome 17 in benign and malignant adrenocortical tumors associated with the Arg337His mutation of the p53 tumor suppressor protein EM Pinto, AEC Billerbeck, MCBV Fragoso, BB Mendonca, AC Latronico The Journal of Clinical Endocrinology & Metabolism 90 (5), 2976-2981, 2005 | 52 | 2005 |
| Molecular analysis of CYP21A2 can optimize the follow‐up of positive results in newborn screening for congenital adrenal hyperplasia EL Silveira, RH Elnecave, EP Dos Santos, V Moura, EM Pinto, ... Clinical genetics 76 (6), 503-510, 2009 | 48 | 2009 |
| Pediatric adrenocortical tumours EM Pinto, GP Zambetti, C Rodriguez-Galindo Best Practice & Research Clinical Endocrinology & Metabolism 34 (3), 101448, 2020 | 47 | 2020 |
| The degree of external genitalia virilization in girls with 21‐hydroxylase deficiency appears to be influenced by the CAG repeats in the androgen receptor gene RO Rocha, AEC Billerbeck, EM Pinto, KFS Melo, CJ Lin, CA Longui, ... Clinical endocrinology 68 (2), 226-232, 2008 | 47 | 2008 |
| XAF1 as a modifier of p53 function and cancer susceptibility EM Pinto, BC Figueiredo, W Chen, HCR Galvao, MN Formiga, ... Science advances 6 (26), eaba3231, 2020 | 44 | 2020 |
| Identification of clinical and biologic correlates associated with outcome in children with adrenocortical tumors without germline TP53 mutations: a St Jude Adrenocortical … EM Pinto, C Rodriguez-Galindo, SB Pounds, L Wang, MR Clay, G Neale, ... Journal of Clinical Oncology 35 (35), 3956, 2017 | 43 | 2017 |
| TP53-associated pediatric malignancies EM Pinto, RC Ribeiro, BC Figueiredo, GP Zambetti Genes & cancer 2 (4), 485-490, 2011 | 42 | 2011 |
| ABO genotyping in leukemia patients reveals new ABO variant alleles MC Novaretti, AE Domingues, R Manhani, EM Pinto, PE Dorlhiac-Llacer, ... Genet Mol Res 7 (1), 87-94, 2008 | 42 | 2008 |
| Establishment and characterization of the first pediatric adrenocortical carcinoma xenograft model identifies topotecan as a potential chemotherapeutic agent EM Pinto, C Morton, C Rodriguez-Galindo, L McGregor, AM Davidoff, ... Clinical cancer research 19 (7), 1740-1747, 2013 | 40 | 2013 |
Berenice Bilharinho de MendonçaFaculdade de Medicina da Universidade de São PauloVerified email at usp.br
